4 Geographic Atrophy Clinical Trials in Walnut Creek, CA (2026)

Q: How do I join a clinical trial in Walnut Creek?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Walnut Creek research site will contact you.

Recruiting Geographic Atrophy Studies in Walnut Creek

NCT06764875Recruiting

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

This is a Phase Ⅲ, randomized, open-label, Sponsor-blinded, 3-arm, global, multicenter study assessing the efficacy and safety of rilvegostomig in combination with fluoropyrimidine and T-DXd (Arm A) c...

Walnut Creek, CAPHASE3840 participantsAstraZeneca

View Study Details

NCT06659445Recruiting

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

The purpose of this study is to collect efficacy and safety information of intravitreal injection for 3 experimental arms, including 2 dose levels of ONL1204 and 2 treatment frequencies in patients wi...

Walnut Creek, CAPHASE2324 participantsONL Therapeutics

View Study Details

NCT07260916Recruiting

Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation

MINUTE is a prospective, multi-center, randomized, controlled, blinded assessor, adaptive enrichment design, clinical trial. Eligible patients with spontaneous BGH ≥20 mL will be randomized 1:1 to eit...

Walnut Creek, CANA300 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT06990269Recruiting

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Phase 2 study is designed to assess the efficacy of ADX-038 compared with placebo in participants with GA secondary to AMD. Safety, pharmacokinetics (PK), and pharmacodynamics (PD) will also be assess...

Walnut Creek, CAPHASE2240 participantsADARx Pharmaceuticals, Inc.

View Study Details

About Geographic Atrophy Clinical Trials in Walnut Creek

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 4 geographic atrophy clinical trials recruiting participants in Walnut Creek, CA. These studies are seeking a combined 1,704 participants. Research is being sponsored by AstraZeneca, ONL Therapeutics, Icahn School of Medicine at Mount Sinai and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Walnut Creek — FAQ

Are there geographic atrophy clinical trials in Walnut Creek?

Yes, there are 4 geographic atrophy clinical trials currently recruiting in Walnut Creek, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Walnut Creek?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Walnut Creek research site will contact you about next steps.

Are clinical trials in Walnut Creek free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Walnut Creek studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 4 active trials in Walnut Creek are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated October 16, 2026 from ClinicalTrials.gov